top of page
Search

Onco-Summaries: Daily Oncology Updates at a Glance

15/07/2025



The first patient has been enrolled in the Phase 3 HARMONi-GI6 trial of ivonescimab + chemo in CRC (Ref)


  • The first patient has been successfully enrolled in the registration Phase 3 AK112-312/HARMONi-GI6 trial of Akeso and Summit's ivonescimab (PD-1 x VEGF BsAb) in first-line treatment for advanced metastatic colorectal cancer (mCRC)


  • The trial is evaluating ivonescimab + FOLFOXIRI vs bevacizumab + FOLFOXIRI


  • Primary completion date: Jan'27


Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page